Bayliss, Douglas A.
- University of Virginia · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,927
- Program Leader
- R01 Holder
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$2.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,927
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Bayliss, Douglas A. as a PI. Multi-PI records show the full award amount for context.
- 5P01HL120840-10P01Contact PIPannexin Channels In Vascular Physiology & InflammationUniversity of Virginia · Pharmacology (NIH department code)$2.4Maward amount
- 5R01HL108609-11R01Contact PICellular/Molecular Mechanisms of Respiratory Neuronal ChemosensitivityUniversity of Virginia · Pharmacology (NIH department code)$484.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Bayliss, Douglas A. as a PI.
FY2023 award administered by University of Virginia (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of Virginia
- 2007$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #6695
- 2011R01 Grant Holder
- 2013$5M Cumulative Funding
- 2014Program/Center Grant Leader
- 2021$10M Cumulative Funding
- 2021Entered Top 25% NationallyRanked #1730
- 2021Entered Top 10% NationallyRanked #1730